Reducing Infection Risks of Anti-BCMA Bispecific Antibodies in Multiple Myeloma: In-Hospital Vs. Hospital-at-Home Treatment

被引：0

作者：

Winer, Romain ^{[1
]}

Vignon, Marguerite ^{[2
]}

Collier, Mathis ^{[3
]}

Fouquet, Guillemette ^{[4
]}

Hermine, Olivier ^{[5
]}

Cazelles, Clarisse ^{[5
]}

Frenzel, Laurent ^{[5
]}

Choquet, Sylvain ^{[6
]}

Garderet, Laurent ^{[7
]}

Merzoug, Karim Belhadj ^{[8
]}

Braun, Thorsten ^{[9
]}

Bouscary, Didier ^{[2
]}

Brandely-Piat, Marie-Laure ^{[2
]}

Leclaire, Clement

Gutierrez, Maya

Moufle, Frederique

Chauvin, Cecile

Soulignac, Arnaud

Zogo, Arsene

Moreau, Philippe ^{[10
]}

Zerbit, Jeremie ^{[1
]}

机构：

[1] Greater Paris Univ Hosp, Hosp Home, AP HP, Paris, France

[2] Greater Paris Univ Hosp, Cochin Hosp, Hematol, AP HP, Paris, France

[3] Greater Paris Univ Hosp, Cochin Hosp, Clin Res Unit, AP HP, Paris, France

[4] Hosp Sud Francilien, Hematol Dept, Corbeil Essonnes, France

[5] Greater Paris Univ Hosp, Necker Hosp, Hematol, AP HP, Paris, France

[6] Hop La Pitie Salpetriere, Paris, France

[7] Greater Paris Univ Hosp, Pitie Salpetriere Hosp, Hematol, AP HP, Paris, France

[8] Greater Paris Univ Hosp, Henri Mondor Hosp, Unit Lymphoid Hemopathies, AP HP, Creteil, France

[9] Greater Paris Univ Hosp, Hosp Avicenne, Hematol, AP HP, Bobigny, France

[10] Univ Hosp Nantes, Hematol, Nantes, France

来源：

BLOOD | 2024年 / 144卷

关键词：

D O I：

10.1182/blood-2024-204695

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2286 / 2287

页数：2

共 13 条

[1] Monoclonal and Bispecific Anti-BCMA Antibodies in Multiple Myeloma
Dalla Palma, Benedetta
Marchica, Valentina
Catarozzo, Maria Teresa
Giuliani, Nicola
Accardi, Fabrizio
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) : 1 - 11
[2] Hospital Vs. Hospital-At-Home Programs For Treatment Of Cap In Uruguay
Gruss, A. I.
Reyes, N.
Mendez, A.
Rivero, F.
Ferreira, J.
Mas, V.
Taborda, A.
Rey, A.
Ganon, J.
Palasti, S.
Facal, J.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
[3] Infections and Severe Hypogammaglobulinemia in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies
Lancman, Guido
Parsa, Kian
Rodriguez, Cesar
Richter, Joshua
Cho, Hearn J.
Parekh, Samir
Richard, Shambavi
Rossi, Adriana
Sanchez, Larysa
Thibaud, Santiago
Jagannath, Sundar
Chari, Ajai
BLOOD, 2022, 140 : 10073 - 10074
[4] Increased risk of infection reporting with anti-BCMA bispecific monoclonal antibodies in multiple myeloma: A worldwide pharmacovigilance study
Contejean, Adrien
Janssen, Cecile
Orsini-Piocelle, Frederique
Zecchini, Celine
Charlier, Caroline
Chouchana, Laurent
AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (12) : E349 - E353
[5] IVIg Use Associated with Ten-Fold Reduction of Serious Infections in Multiple Myeloma Patients Treated with Anti-BCMA Bispecific Antibodies
Lancman, Guido
Parsa, Kian
Kotlarz, Krzysztof
Avery, Lisa
Lurie, Alaina
Lieberman-Cribbin, Alex
Cho, Hearn Jay
Parekh, Samir S.
Richard, Shambavi
Richter, Joshua
Rodriguez, Cesar
Rossi, Adriana
Sanchez, Larysa J.
Thibaud, Santiago
Jagannath, Sundar
Chari, Ajai
BLOOD CANCER DISCOVERY, 2023, 4 (06): : 440 - 451
[6] Infection Risk and Use of Prophylaxis with Anti-BCMA Bispecific T Cell Engagers and Belantamab Mafodotin for Patients with Relapsed and Refractory Multiple Myeloma
Popat, Rakesh
Cheok, Kathleen
Sridhar, Amrutha
Feely, Conor
Mactier, Catriona
Mcmillan, Annabel
Wechalekar, Ashutosh D.
Rabin, Neil
Sive, Jonathan
Kyriakou, Charalampia
Xu, Ke
Papanikolaou, Xenofon
Mahmood, Shameem
Yong, Kwee
Lee, Lydia Sarah Hui
BLOOD, 2023, 142
[7] Preclinical pharmacology and safety of RO7297089, a novel anti-BCMA/CD16a bispecific antibody for the treatment of multiple myeloma
Kakiuchi-Kiyota, Satoko
Schutten, Melissa M.
Adedeji, Adeyemi O.
Cai, Hao
Hendricks, Robert
Liu, Luna
Cohen, Sivan
Fullerton, Aaron M.
Corr, Nicholas
Yu, Lanlan
Nagata, Denise de Almeida
Zhong, Shelly
Dillon, Michael
Spiess, Christoph
Leong, Steve R.
Zheng, Bing
Wingert, Susanne
Reusch, Uwe
Knackmuss, Stefan
Ross, Thorsten
Polson, Andrew
Ovacik, Ayse M.
CANCER RESEARCH, 2020, 80 (16)
[8] Nonclinical Pharmacokinetics, Pharmacodynamics, and Translational Model of RO7297089, A Novel Anti-BCMA/CD16A Bispecific Tetravalent Antibody for the Treatment of Multiple Myeloma
Cai, Hao
Kakiuchi-Kiyota, Satoko
Hendricks, Robert
Zhong, Shelly
Liu, Luna
Adedeji, Adeyemi O.
Chan, Pamela
Schutten, Melissa M.
Kamath, Amrita, V
Ovacik, Meric A.
AAPS JOURNAL, 2022, 24 (06):
[9] Cost-effectiveness of home-based vs. in-hospital treatment of paediatric tuberculous meningitis
van Elsland, S. L.
van Dongen, S., I
Bosmans, J. E.
Schaaf, H. S.
van Toorn, R.
van Furth, A. M.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2018, 22 (10) : 1188 - +
[10] Nonclinical Pharmacokinetics, Pharmacodynamics, and Translational Model of RO7297089, A Novel Anti-BCMA/CD16A Bispecific Tetravalent Antibody for the Treatment of Multiple Myeloma
Hao Cai
Satoko Kakiuchi-Kiyota
Robert Hendricks
Shelly Zhong
Luna Liu
Adeyemi O. Adedeji
Pamela Chan
Melissa M. Schutten
Amrita V. Kamath
Meric A. Ovacik
The AAPS Journal, 24

← 1 2 →